Percutaneous coronary intervention of chronic total occlusion - to whom, when and why

Vnitrni Lekarstvi
|July 19, 2021
PubMed

Insights

Chronic total occlusion (CTO) involves a complete blockage in a coronary vessel for over three months. Successful percutaneous intervention for CTO improves exercise capacity and quality of life.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Chronic total occlusion (CTO) is defined as a complete cessation of blood flow in a coronary artery for at least three months.
  • Distal arterial segments are typically supplied by collateral circulation, which may preserve myocardial viability but often fails to prevent exercise-induced ischemia.
  • CTO is associated with poorer outcomes in patients with acute coronary syndromes affecting non-infarct-related arteries.

Purpose of the Study:

  • To evaluate the impact of percutaneous intervention for CTO on ischemia reduction, exercise capacity, and quality of life.
  • To assess the effect of successful CTO recanalization on left ventricular systolic function.
  • To understand the short- and long-term outcomes of patients with CTO, particularly in the context of acute coronary syndromes.

Main Methods:

  • Review of percutaneous coronary intervention (PCI) techniques for CTO.
  • Analysis of procedural success rates and complication rates in contemporary CTO interventions.
  • Evaluation of clinical outcomes, including exercise capacity, quality of life, and left ventricular function, following CTO recanalization.

Main Results:

  • Successful recanalization of CTO leads to improved left ventricular systolic function.
  • Percutaneous intervention for CTO aims to reduce ischemia and enhance exercise capacity and quality of life.
  • Technological advancements and experienced operators have significantly improved success rates and maintained acceptable complication rates in CTO interventions.

Conclusions:

  • Percutaneous intervention for CTO offers significant benefits in improving patient outcomes and quality of life.
  • CTO interventions have evolved with improved success rates and manageable complications.
  • Addressing CTO is crucial for improving cardiac function and patient prognosis, especially in acute coronary syndromes.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
65
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
83
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
182
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
54
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
96